Efficacy of omalizumab in the treatment of nasal polyps

Thorax

Volumn 66, Issue 9, 2011, Pages 824-825

  Vennera, María Del Carmen ^a   Picado, César ^a   Mullol, Joaquim ^b   Alobid, Isam ^b   Bernal Sprekelsen, Manuel ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E; OMALIZUMAB;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; NOSE POLYP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHINOSINUSITIS; TREATMENT DURATION; TUMOR VOLUME;

EID: 80051895015     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.152835     Document Type: Letter

References (5)

1. Holgate S., Buhl R., Bousquet J., et al. The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update. Respir Med 2009;103:1098-1113
2. Verbruggen K., Van Cauwenberge P., Bachert C. Anti-IgE for the treatment of allergic rhinitis - and eventually nasal polyps? Int Arch Allergy Immunol 2009;148:87-98.
3. Penn R., Mikula S. The role of anti-IgE immunoglobulin therapy in nasal polyposis: A pilot study. Am J Rhinol 2007;21:428-432 (Pubitemid 47360029)
4. Guglielmo M., Gulotta C., Mancini F., et al. Recalcitrant nasal polyposis: Achievement of total remission following treatment with omalizumab. J Investig Allergol Clin Immunol 2009;19:158-159
5. Fokkens W., Lund V., Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps group. Rhinol Suppl. 2007;(20):1-136. Review.